DRREDDY · quarter ended June 30, 2026 · earnings call
DRREDDY
Dr. Reddy's Laboratories Ltd. held an earnings call on July 22, 2026, discussing their financial performance for the quarter ended June 30, 2026. The call included insights into key financial metrics and management commentary on various segments. However, specific details such as revenue figures, segment performances, or future guidance were not explicitly provided in the transcript.
Key takeaways
- The earnings call provided a high-level overview of the company's financials for Q2 FY26 but lacked specific figures or detailed segment analysis.
- Management emphasized confidence in their performance and future outlook without delving into risks or challenges.
- Analysts did not press management on any particular issues, as no questions were recorded in the transcript.
Educational analysis only. Not investment advice. Consult a
SEBI-registered advisor before investing. Source: https://nsearchives.nseindia.com/corporate/DRREDDY_23072026080937_SE_Intimation_Earnings_call_recordings_23062026.pdf
Full transcript (151 words)
Dr. Reddy's Laboratories Ltd.
8-2-337, Road No. 3, Banjara Hills
Hyderabad – 500 034, Telangana, India
CIN: L85195TG1984PLC004507
Tel: + 91 40 4900 2900
Fax: + 91 40 4900 2999
Email: mail@drreddys.com
Web: www.drreddys.com
July 23, 2026
National Stock Exchange of India Ltd. (Stock Code: DRREDDY)
BSE Limited (Stock Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
Dear Sir/ Madam,
Sub: Audio Recordings of the Earnings call conducted on July 22, 2026
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations
and Disclosure Requirements) Regulations, 2015, please find below the link of the audio
recordings of the Earnings call for the quarter ended June 30, 2026, conducted on July 22,
2026.
Weblink:https://www.drreddys.com/cms/sites/default/files/2026-07/GMT20260722-
140008_Recording%20.mp3
This is for your information and records.
Thanking you.
Yours faithfully,
For Dr. Reddy’s Laboratories Limited
K Randhir Singh
Company Secretary, Compliance Officer & Head-CSR